These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 15331168

  • 1. Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker.
    Linder S, Havelka AM, Ueno T, Shoshan MC.
    Cancer Lett; 2004 Oct 08; 214(1):1-9. PubMed ID: 15331168
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18.
    Kramer G, Erdal H, Mertens HJ, Nap M, Mauermann J, Steiner G, Marberger M, Bivén K, Shoshan MC, Linder S.
    Cancer Res; 2004 Mar 01; 64(5):1751-6. PubMed ID: 14996736
    [Abstract] [Full Text] [Related]

  • 4. Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker.
    Olofsson MH, Cummings J, Fayad W, Brnjic S, Herrmann R, Berndtsson M, Hodgkinson C, Dean E, Odedra R, Wilkinson RW, Mundt KE, Busk M, Dive C, Linder S.
    Cancer Biomark; 2009 Mar 01; 5(3):117-25. PubMed ID: 19407366
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [High values of soluble cytokeratin 18 in breast carcinomas may have different meanings].
    Cianga P, Cianga C, Anisie E, Zlei M, Ungureanu D, Munteanu D, Chifu C, Diaconu C, Carasevici E.
    Rev Med Chir Soc Med Nat Iasi; 2005 Mar 01; 109(4):836-40. PubMed ID: 16610185
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells.
    Shi RX, Ong CN, Shen HM.
    Cancer Res; 2005 Sep 01; 65(17):7815-23. PubMed ID: 16140950
    [Abstract] [Full Text] [Related]

  • 14. Clinical utility of cytokeratins as tumor markers.
    Barak V, Goike H, Panaretakis KW, Einarsson R.
    Clin Biochem; 2004 Jul 01; 37(7):529-40. PubMed ID: 15234234
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW, Shah S.
    Asia Pac J Clin Nutr; 2005 Jul 01; 14(4):366-73. PubMed ID: 16326643
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.